Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Balasch, J.
Right arrow Articles by Vanrell, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balasch, J.
Right arrow Articles by Vanrell, J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 2, No. 7, pp. 557-567, 1987
© 1987 European Society of Human Reproduction and Embryology

research-article

Corpus luteum insufficiency and fertility: a matter of controversy

Juan Balasch and Juan A. Vanrell

Department of Obstetrics and Gynaecology, Facultad de Medicina, Hospital Clínico y Provincial C/Casanova 143, 08036-Barcelona, Spain

This paper analyses different controversial aspects of luteal phase deficiency (LPD) on the basis of our own data and current clinical experience. Conceptual and diagnostic concerns include: (i) the lack of predictive value of mid-luteal plasma progesterone determinations regarding the progestational transformation of the endometrium, and (ii) the need for a minimum of two, or even three, endometrial biopsies for diagnosis of LPD. From an aetiologic point of view follicular phase determinants of LPD are emphasized and conflicting data on claimed predisposing factors of LPD are analysed. Primary therapeutic approaches to LPD and the effectiveness and significance of such therapy on fertility are discussed.

Key words: corpus luteum insufficiency/luteal phase deficiency and fertility/plasma progesterone/endometrial biopsy/endometrial receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
J. Szekeres-Bartho and J. Balasch
Progestagen therapy for recurrent miscarriage
Hum. Reprod. Update, January 1, 2008; 14(1): 27 - 35.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Ordi, M. Creus, L. Quinto, R. Casamitjana, A. Cardesa, and J. Balasch
Within-Subject Between-Cycle Variability of Histological Dating, {alpha}v{beta}3 Integrin Expression, and Pinopod Formation in the Human Endometrium
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2119 - 2125.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, F. Carmona, A. Cardesa, J. A. Vanrell, and J. Balasch
The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study
Hum. Reprod., April 1, 2003; 18(4): 683 - 693.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, B. Ferrer, E. Coll, J. A. Vanrell, and J. Balasch
{alpha}v{beta}3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women
Hum. Reprod., September 1, 2002; 17(9): 2279 - 2286.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, J. A. Vanrell, and J. Balasch
Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation
Hum. Reprod., July 1, 2001; 16(7): 1347 - 1352.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.